AllGen Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,140
Closed -$5.66M 41
2024
Q4
$5.66M Buy
39,140
+696
+2% +$108K 1.9% 15
2024
Q3
$6.23M Buy
38,444
+2,356
+7% +$375K 2.02% 16
2024
Q2
$5.27M Buy
36,088
+4,443
+14% +$661K 2% 13
2024
Q1
$5.01M Buy
+31,645
New +$5.04M 2.04% 12
2023
Q3
Sell
-31,677
Closed -$5.24M 32
2023
Q2
$5.24M Buy
31,677
+517
+2% +$83.4K 3.3% 9
2023
Q1
$4.83M Buy
31,160
+303
+1% +$48.9K 3.37% 8
2022
Q4
$5.45M Sell
30,857
-1,048
-3% -$181K 3.91% 6
2022
Q3
$5.21M Sell
31,905
-649,201
-95% -$110M 4.06% 7
2022
Q2
$6.74M Buy
681,106
+657,233
+2,753% +$117M 5.54% 6
2022
Q1
$4.23M Sell
23,873
-349
-1% -$59.4K 3.53% 8
2021
Q4
$4.14M Sell
24,222
-5,167
-18% -$846K 3.07% 9
2021
Q3
$4.75M Buy
29,389
+2,552
+10% +$435K 3.87% 7
2021
Q2
$4.42M Buy
26,837
+1,178
+5% +$195K 3.39% 9
2021
Q1
$4.22M Sell
25,659
-32,047
-56% -$5.19M 3.45% 7
2020
Q4
$3.99M Buy
+57,706
New +$8.52M 3.7% 7

Other funds holding JNJ

AllGen Financial Advisors's JNJ Position: Q1 2025 in Review

AllGen Financial Advisors sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 39,140 shares — an estimated $5.66M sold.

AllGen Financial Advisors first reported a position in JNJ in Q4 2020 and held it in 15 quarters. The position peaked at $6.74M in Q2 2022. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • AllGen Financial Advisors reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • AllGen Financial Advisors sold 39,140 Johnson & Johnson shares in Q1 2025, an estimated $5.66M.
  • AllGen Financial Advisors first reported a position in Johnson & Johnson in Q4 2020 and held it in 15 quarters.
  • AllGen Financial Advisors's Johnson & Johnson position peaked at $6.74M in Q2 2022.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on AllGen Financial Advisors's 13F filing for Q1 2025, filed 6 May 2025.